Edwards Lifesciences Corporation (EW) — Business segments and KPIs
Revenue by business segment and geography for Edwards Lifesciences Corporation, with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Transcatheter Heart Valves | 4.49B | 74.0% |
| Surgical Heart Valve Therapy | 1.03B | 17.0% |
| Transcatheter Mitral And Tricuspid Therapies | 550.6M | 9.1% |
| Revenue by region | ||
| UNITED STATES | 3.54B | 58.4% |
| Europe | 1.52B | 25.0% |
| Rest of World | 652.3M | 10.8% |
| JAPAN | 354.7M | 5.8% |